Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia

References

• PuiC-HEvansWEAcute lymphoblastic leukemiaN Engl J Med19983396056159718381
   PubMed Web of Science ®Google Scholar
• PietersRCarrollWLBiology and treatment of acute lymphoblastic leukemiaHematol Oncol Clin North Am20102411820113893
   PubMed Web of Science ®Google Scholar
• BiondiACiminoGPietersRPuiC-HBiological and therapeutic aspects of infant leukemiaBlood200096243310891426
   PubMed Web of Science ®Google Scholar
• BehmFGRaimondiSCFrestedtJLRearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting ageBlood199687287028778639906
   PubMed Web of Science ®Google Scholar
• PuiC-HGaynonPSBoyettJMOutcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal regionLancet20023591909191512057554
   PubMed Web of Science ®Google Scholar
• ChenCSSorensenPHReamanGHMolecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcomesBlood199381238623938481519
   PubMed Web of Science ®Google Scholar
• RubnitzJELinkMPShusterJJFrequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group studyBlood1994845705738025282
   PubMed Web of Science ®Google Scholar
• HildenJMDinndorfPAMeerbaumSOAnalysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children’s Oncology GroupBlood200610844145116556894
   PubMed Web of Science ®Google Scholar
• RubnitzJEGibsonBSmithFOAcute myeloid leukemiaHematol Oncol Clin North Am201024356320113895
   PubMed Web of Science ®Google Scholar
• MartensJHAStunnenbergHGThe molecular signature of oncofusion proteins in acute myeloid leukemiaFEBS Lett20105842662266920388510
   PubMed Web of Science ®Google Scholar
• TamaiHInokuchiK11q23/MLL acute leukemia: update of clinical aspectsJ Clin Exp2010509198
   Google Scholar
• DrexlerHGQuentmeierHMacLeodRAMalignant hematopoietic cell lines: in vitro models for the study if MLL gene alterationsLeukemia20041822723214671638
   PubMed Web of Science ®Google Scholar
• Development Therapeutics Program [homepage on the Internet]NCI/NIH Available from: http://dtp.cancer.govAccessed July 23, 2011
   Google Scholar
• NabzdykCSChunMPradhanLLoGerfoFWHigh throughput RNAi assay optimization using adherent cell cytometryJ Transl Med20119485621518450
   PubMed Web of Science ®Google Scholar
• NarendranAGanjaviHMorsonNMutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growthExp Hematol20033169370112901974
   PubMed Web of Science ®Google Scholar
• JayanthanAIncoronatoASinghACytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangementsPediatr Blood Cancer20115635336021225911
   PubMed Web of Science ®Google Scholar
• BattkeFSymonsSNieseltKMayday – integrative analytics for expression dataBMC Bioinformatics20101112113020214778
   PubMed Web of Science ®Google Scholar
• FineBMStanullaMSchrappeMGene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemiaBlood20041031043104914525776
   PubMed Web of Science ®Google Scholar
• ArmstrongSAStauntonJESilvermanLBMLL translocations specify a distinct gene expression profile that distinguishes a unique leukemiaNat Genet200230414711731795
   PubMed Web of Science ®Google Scholar
• YeohE-JRossMEShurtleffSAClassification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingCancer Cell2002113314312086872
   PubMed Web of Science ®Google Scholar
• RossMEZhouXSongGClassification of pediatric acute lymphoblastic leukemia by gene expression profilingBlood20031022951295912730115
   PubMed Web of Science ®Google Scholar
• AnderssenAEdenPOlofssonTGene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignanciesBMC Med Genomics2010361420211010
   PubMed Web of Science ®Google Scholar
• RossMEMahfouzROnciuMGene expression profiling of pediatric acute myelogenous leukemiaBlood20041043679368715226186
   PubMed Web of Science ®Google Scholar
• Voskoglou-NomikosTPaterJLSeymourLClinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer modelsClin Cancer Res200394227423914519650
   PubMed Web of Science ®Google Scholar
• SigalDSMillerHJSchramEDSavenABeyond hairy cell: the activity of cladribine in other hematologic malignanciesBlood20101162884289620634380
   PubMed Web of Science ®Google Scholar
• SantanaVMHurwitzCaBlakelyRLComplete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemiaBlood199484123712427914104
   PubMed Web of Science ®Google Scholar
• SantanaVMMirroJJrKeamsCSchellMJCromWBlakleyRL2-chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemiaJ Clin Oncol1992103643701346800
   PubMed Web of Science ®Google Scholar
• GandhiVEsteyEKeatingMJChucrallahAPlunkettWChlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactionsBlood1996872562648547650
   PubMed Web of Science ®Google Scholar
• CrewsKRWimmerPSHudsonJQHowardSCRibeiroRCRazzoukBIPharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failureJ Pediat Hematol Onc200224677680
   PubMed Web of Science ®Google Scholar
• KolbEASteinherzPGA new multidrug induction protocol with topotecan, vinorelbine, thiotepa, dexamethasone and gemcitabine for relapsed or refractory acute leukemiaLeukemia2003171967197214513046
   PubMed Web of Science ®Google Scholar
• HiwarkarPArkenauH-TTreleavenJMorganGPotterMEthellMThe feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphomaLeukemia2008221627162918305560
   PubMed Web of Science ®Google Scholar
• EgertonNOptimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancerCancer Chemoth Pharm20106610051012
   Web of Science ®Google Scholar
• JacobsSFoxEKrailoMPhase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the Children’s Oncology GroupClin Cancer Res20101675075420068084
   PubMed Web of Science ®Google Scholar
• KangMHSmithMAMortonCLKeshelavaNHoughtonPJReynoldsCPNational Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testingPediatr Blood Cancer20115623924920922763
   PubMed Web of Science ®Google Scholar
• LammDLMcGeeWRHaleKBladder cancer: current optimal intravesical treatmentUrol Nurs20052532333216294610
   PubMedGoogle Scholar
• AndersenSMRosadaCDagnaes-HansenFTopical application of valrubicin has a beneficial effect on developing skin tumorsCarcinogenesis2010311483149020554745
   PubMed Web of Science ®Google Scholar
• RavandiFIssaJ-PGarcia-ManeroGSuperior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalitiesCancer20091155746575119795507
   PubMed Web of Science ®Google Scholar
• BryanJJabbourEPrescottHGarcia-ManeroGIssaJPKantarjianHCurrent and future management options for myelodysplastic syndromesDrugs2010701381139420614946
   PubMed Web of Science ®Google Scholar
• ParikhSAHagopKGarcia-ManeroGClofarabine plus low-dose cytarabine induction followed by consolidation with clofarabine plus low-dose cytarabine alternating with decitabine as frontline therapy for patients (pts) with acute myeloid leukemia (AML) = 60 years (yrs)Blood2009114Abstract 2058
   Web of Science ®Google Scholar
• RitchieEKArnasonJFeldmanEJDecitabine-based salvage therapy in adults with acute myeloid leukemiaBlood2009l114Abstract 2063
   Google Scholar
• DutcherJPColettiDPaiettaEWiernikPHA pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemiaLeuk Res1997213753429225062
   PubMed Web of Science ®Google Scholar
• ArchimbaudETroncyJSebbanCPhase II trial of plicamycin and hydroxyurea in acute myelogenous leukemiaCancer Chemoth Pharm198925223225
   Web of Science ®Google Scholar
• GreilJGramatzkiMBurgerRThe acute lymphoblastic leukemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7Br J Haematol1994862752838199015
   PubMed Web of Science ®Google Scholar
• CohenABrunbergerTVanekWConstitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemic cell lineBlood199178941021648979
   PubMed Web of Science ®Google Scholar
• MatsuoYDrexlerHGEstablishment and characterization of human B cell precursor-leukemia cell linesLeuk Res1998225675799680106
   PubMed Web of Science ®Google Scholar
• MinowadaJOhnumaTMooreGERosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytesJ Natl Cancer I197249891894
   PubMed Web of Science ®Google Scholar
• TsuchiyaSYamabeMYamaguchiYKobayashiYKonnoTTadaKEstablishment and characterization of a human acute monocytic leukemia cell line (THP-1)Int J Cancer1980261711766970727
   PubMed Web of Science ®Google Scholar
• AdatiNHuangM-CSuzukiTSuzukiHKojimaTHigh-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell lineBMC Res Notes2009215315919635138
   PubMedGoogle Scholar